← Back to Clinical Trials
Recruiting NCT06318780

NCT06318780 Concordance of Three Imaging Methods by Dynamic CT, Contrast Ultrasound and CT Angiography in the Characterization of Endoleaks in Patients With an Aortic Endoprosthesis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06318780
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire, Amiens
Condition Aortic Diseases
Study Type INTERVENTIONAL
Enrollment 69 participants
Start Date 2024-02-28
Primary Completion 2029-02

Trial Parameters

Condition Aortic Diseases
Sponsor Centre Hospitalier Universitaire, Amiens
Study Type INTERVENTIONAL
Phase N/A
Enrollment 69
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-02-28
Completion 2029-02
Interventions
three-phase CT angiographyCEUS ultrasound

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Among patients who have undergone EVAR, there is a significant risk of 20-50% endoleak. These endoleaks often require secondary interventions to reduce the risk of expansion or rupture. Currently, three-phase CT angiography and CEUS ultrasound are recommended in the post-operative monitoring of EVAR but these remain limited in characterizing the type and source of endoleak. In this study the investigators will study the interest of d-CTA for a better detection and characterization of endoleaks.

Eligibility Criteria

Inclusion Criteria: * Patients 18 years of age and older, * Patients who have received EVAR , * Detection of endoleak and/or with an aneurysmal sac enlargement greater than or equal to 5 mm over 6 months. Exclusion Criteria: * Minor patients, * absence of endoleak and growth of the aneurysmal sac (greater than or equal to 5 mm over 6 months), * patient under guardianship, curators, safeguard of justice, * patient deprived of liberty, * pregnant woman * Patient who does not benefit from a social security scheme

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology